(Q38419642)

2 September 2017

title

Initial experience with non-invasive prenatal testing of cell-free DNA for major chromosomal anomalies in a clinical setting (English)

1 reference

2 September 2017

Carmina Comas

1

1 reference

2 September 2017

Mónica Echevarria

2

1 reference

2 September 2017

M Angeles Rodríguez

3

1 reference

2 September 2017

Pilar Prats

4

1 reference

2 September 2017

Ignacio Rodríguez

5

1 reference

2 September 2017

Bernat Serra

6

1 reference

2 September 2017

publication date

12 August 2014

1 reference

Journal of Maternal-Fetal and Neonatal Medicine

2 September 2017

published in

1 reference

2 September 2017

volume

28

1 reference

2 September 2017

issue

10

1 reference

2 September 2017

page(s)

1196-1201

1 reference

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

First-trimester or second-trimester screening, or both, for Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Prospective validation of first-trimester combined screening for trisomy 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Screening for fetal aneuploidies at 11 to 13 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

DNA Sequencing versus Standard Prenatal Aneuploidy Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2014.947579

10.3109/14767058.2014.947579

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference